A, P., L, F., P, G., & J, W. (2015). Activation of wild-type p53 by MDM2 inhibitors: A new strategy for lymphoma treatment. Dove Medical Press.
Chicago Style (17th ed.) CitationA, Pujals, Favre L, Gaulard P, and Wiels J. Activation of Wild-type P53 by MDM2 Inhibitors: A New Strategy for Lymphoma Treatment. Dove Medical Press, 2015.
MLA (8th ed.) CitationA, Pujals, et al. Activation of Wild-type P53 by MDM2 Inhibitors: A New Strategy for Lymphoma Treatment. Dove Medical Press, 2015.
Warning: These citations may not always be 100% accurate.